Overview
Lenita Zajdenverg practices practicing medicine in Rio De Janeiro, Brazil.
Ms. Zajdenverg is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Type 1 Diabetes (T1D), Gestational Diabetes, and Metabolic Syndrome.
She is actively involved in clinical research, co-authoring 90 peer reviewed articles and participating in 1 clinical trial.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Lenita Zajdenverg
Is Lenita Zajdenverg a top-rated expert for Familial Partial Lipodystrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Lenita Zajdenverg is classified as an Distinguished expert for Familial Partial Lipodystrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lenita Zajdenverg participate in research or clinical trials?
Yes. Lenita Zajdenverg has published 90 articles and abstracts on conditions like Familial Partial Lipodystrophy. You can view a list of Lenita Zajdenverg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Partial LipodystrophyMs. Zajdenverg isDistinguished. Learn about Familial Partial Lipodystrophy.
- Type 1 Diabetes (T1D)Ms. Zajdenverg isDistinguished. Learn about Type 1 Diabetes (T1D).
- Advanced
- Gestational DiabetesMs. Zajdenverg isAdvanced. Learn about Gestational Diabetes.
- Metabolic SyndromeMs. Zajdenverg isAdvanced. Learn about Metabolic Syndrome.
- Type 2 Diabetes (T2D)Ms. Zajdenverg isAdvanced. Learn about Type 2 Diabetes (T2D).
- Experienced
- Acanthosis NigricansMs. Zajdenverg isExperienced. Learn about Acanthosis Nigricans.
- Congenital Generalized LipodystrophyMs. Zajdenverg isExperienced. Learn about Congenital Generalized Lipodystrophy.
- Congenital HyperinsulinismMs. Zajdenverg isExperienced. Learn about Congenital Hyperinsulinism.
- Diabetic KetoacidosisMs. Zajdenverg isExperienced. Learn about Diabetic Ketoacidosis.
- Familial HypertriglyceridemiaMs. Zajdenverg isExperienced. Learn about Familial Hypertriglyceridemia.
- High CholesterolMs. Zajdenverg isExperienced. Learn about High Cholesterol.
- HypertensionMs. Zajdenverg isExperienced. Learn about Hypertension.
- HypotoniaMs. Zajdenverg isExperienced. Learn about Hypotonia.
- Low Blood SugarMs. Zajdenverg isExperienced. Learn about Low Blood Sugar.
- Maturity Onset Diabetes of the YoungMs. Zajdenverg isExperienced. Learn about Maturity Onset Diabetes of the Young.
- MelasmaMs. Zajdenverg isExperienced. Learn about Melasma.
- MumpsMs. Zajdenverg isExperienced. Learn about Mumps.
- Newborn Low Blood SugarMs. Zajdenverg isExperienced. Learn about Newborn Low Blood Sugar.
- ObesityMs. Zajdenverg isExperienced. Learn about Obesity.
- PeriodontitisMs. Zajdenverg isExperienced. Learn about Periodontitis.
- PreeclampsiaMs. Zajdenverg isExperienced. Learn about Preeclampsia.
- Retinal Vein OcclusionMs. Zajdenverg isExperienced. Learn about Retinal Vein Occlusion.
- RubellaMs. Zajdenverg isExperienced. Learn about Rubella.
- ThrombophlebitisMs. Zajdenverg isExperienced. Learn about Thrombophlebitis.
- Type A Insulin Resistance SyndromeMs. Zajdenverg isExperienced. Learn about Type A Insulin Resistance Syndrome.